News

The company consolidates its growth, driven by the integration of SIFI and Edol, as well as the strong performance of international direct-to-consumer markets, particularly in Latin America The ophthalmology division now accounts […]

The Group’s total revenue stands at 391.5 million euros (+27%), with the Farma division reaching 340 million euros (+28%), driven by international growth and the consolidation of the ophthalmology business. EBITDA reached […]

The company has signed an exclusive licensing and supply agreement with Dongkook Pharmaceutical to register and commercialize Uresco in 13 Latin American countries. The agreement includes a total amount of up to […]